Data to be presented will highlight the progress of SAB BIO’s lead program, SAB-142, a potentially best-in-class, disease-modifying, redosable immunotherapy in clinical development for delaying the ...
Study met its primary endpoint demonstrating that GRI-0621 was well tolerated over 12 weeks of treatment, with no drug-related severe or serious ...
VTP-1000, an antigen-specific immunotherapy to treat celiac disease, showed a dose-dependent pharmacological effect in the ...
Official data shows that Uttar Pradesh has produced 182 crore litres of ethanol till November 2025, the highest in its ...
Meet 'Confessions of a Shopaholic' author Sophie Kinsella's four sons and one daughter, whom she leaves behind following her ...
Analysts at Jefferies see blockbuster potential in zorevunersen in Dravet syndrome, with sales potentially reaching $1 ...
Bio-Techne Corporation (TECH) 53rd Annual Nasdaq Investor Conference December 9, 2025 4:30 AM ESTCompany ParticipantsKim Kelderman - CEO, President ...
Detailed price information for Assembly Biosciences (ASMB-Q) from The Globe and Mail including charting and trades.
Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread ...
Vietnam Investment Review on MSN
Essential document checklist for SIM applications now available
SINGAPORE - Media OutReach Newswire - 6 December 2025 - Submitting an application to the Singapore Institute of Management (SIM) represents a significant academic milestone and requires meticulous ...
Ghent is boosting its biopharma hub with cutting-edge infrastructure, world-class research, and a thriving life sciences ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback